1. Home
  2. BMRN vs ERJ Comparison

BMRN vs ERJ Comparison

Compare BMRN & ERJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • ERJ
  • Stock Information
  • Founded
  • BMRN 1996
  • ERJ 1969
  • Country
  • BMRN United States
  • ERJ Brazil
  • Employees
  • BMRN N/A
  • ERJ N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • ERJ Aerospace
  • Sector
  • BMRN Health Care
  • ERJ Industrials
  • Exchange
  • BMRN Nasdaq
  • ERJ Nasdaq
  • Market Cap
  • BMRN 12.1B
  • ERJ 11.0B
  • IPO Year
  • BMRN 1999
  • ERJ 2000
  • Fundamental
  • Price
  • BMRN $59.01
  • ERJ $47.82
  • Analyst Decision
  • BMRN Buy
  • ERJ Buy
  • Analyst Count
  • BMRN 23
  • ERJ 6
  • Target Price
  • BMRN $93.73
  • ERJ $50.40
  • AVG Volume (30 Days)
  • BMRN 1.8M
  • ERJ 2.2M
  • Earning Date
  • BMRN 08-04-2025
  • ERJ 08-07-2025
  • Dividend Yield
  • BMRN N/A
  • ERJ 0.10%
  • EPS Growth
  • BMRN 152.82
  • ERJ 70.71
  • EPS
  • BMRN 2.71
  • ERJ 0.52
  • Revenue
  • BMRN $2,950,227,000.00
  • ERJ $6,519,769,233.00
  • Revenue This Year
  • BMRN $12.27
  • ERJ N/A
  • Revenue Next Year
  • BMRN $9.99
  • ERJ $13.68
  • P/E Ratio
  • BMRN $21.81
  • ERJ $91.15
  • Revenue Growth
  • BMRN 19.36
  • ERJ 39.31
  • 52 Week Low
  • BMRN $52.93
  • ERJ $26.04
  • 52 Week High
  • BMRN $94.85
  • ERJ $61.65
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 55.66
  • ERJ 36.16
  • Support Level
  • BMRN $56.48
  • ERJ $48.17
  • Resistance Level
  • BMRN $60.43
  • ERJ $50.35
  • Average True Range (ATR)
  • BMRN 1.52
  • ERJ 2.12
  • MACD
  • BMRN 0.23
  • ERJ -1.03
  • Stochastic Oscillator
  • BMRN 64.05
  • ERJ 2.31

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About ERJ Embraer S.A.

Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment.

Share on Social Networks: